GlassScriptPhysician profile
Muhammad Asad Hanif
NPI 1619588761
$2,139.55
in general payments reported to CMS, 2019-2025
12 companies · $774 in 2025
The $774 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $309 · 2024: $1,057 · 2025: $774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,797 · Education: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.12 |
| Education | $342.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $573.55 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $543.00 | 2023-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $325.07 | 2024-2025 | Ensite, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $278.28 | 2023-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $122.63 | 2023-2024 | Xarelto |
| Abiomed | $103.18 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $77.16 | 2023-2025 | Brilinta, Lokelma, Farxiga |
| Boston Scientific Corporation | $29.32 | 2024 | |
| Teleflex LLC | $24.59 | 2025 | Guideliner |
| Lantheus Medical Imaging, INC. | $22.26 | 2025 | |
| Edwards Lifesciences Corporation | $21.06 | 2023 | Sapien 3 Ultra Resilia |
| Scpharmaceuticals INC. | $19.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Asad Hanif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.